Medline's results bring a raised outlook, a new buyback and a debt paydown

Medline Inc. The timing and scale of the reaction point to the results themselves, not a broader market move, as the explanation.

A guidance raise, a buyback and a debt prepayment

Net sales rose 10.4% to $7.9 billion in the quarter, with Organic Sales up 10.5%, which the release attributed mainly to existing-customer growth and new contracts signed in 2025. Adjusted EBITDA rose 11.8% to $960 million, outpacing sales growth as net IEEPA tariff refund benefits helped offset higher operating expenses. Adjusted diluted earnings per share were $0.44. Management raised its full-year Organic Sales guidance to a range of 10.0% to 10.5%, up from 9.0% to 10.0%, while reaffirming Adjusted EBITDA guidance of $3.3 billion to $3.4 billion.

A GAAP profit decline tied to a one-off fire cost

GAAP profit told a less generous story. Third-quarter net income, measured before the allocation to noncontrolling interests, fell 1.2% to $318 million; net income attributable to Medline Inc. fell 39.4% to $195 million, with diluted earnings per share of $0.22. Over the first nine months, net income fell 28.8% to $696 million, which the company attributed mainly to higher operating expenses, increased cost of goods sold including tariffs, customer and segment mix, and a $316 million net loss tied to a fire at its distribution centre in Tracy, California.

A move far outside Medline's normal range

The scale of Wednesday's reaction stands out against the stock's own trading history. Medline's shares have typically moved about 2.8% a day over the past year; Wednesday's gain was 6.5x that, and the largest move in this direction since 18 December 2025. Medline's full company analysis sets this quarter against its longer margin and cash-flow history.

What this does to our valuation model

Our valuation model, updated daily, is shown below. These are model values under stated assumptions, not a comparison with the share price.

Confirmation of Wednesday's reaction would come from the next quarterly report, which would show whether the raised Organic Sales guidance of 10.0% to 10.5% holds, whether the $1 billion buyback is executed as announced, and whether GAAP profit recovers once the Tracy fire costs roll off. A further GAAP profit decline without a comparable one-off explanation would sit awkwardly against this quarter's description of "strong cash generation."